Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...
Money Talks News on MSN
CRISPR cures cholesterol, FDA demands testing
Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...
What if a cup of coffee could help treat cancer? Researchers at the Texas A&M Health Institute of Biosciences and Technology ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) expected to beat earnings estimates: Should you buy?
CRISPR Therapeutics AG (CRSP) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports ...
The United Arab Emirates and Colossal Biosciences have announced the creation of the first Colossal BioVault and World ...
Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...
The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...
Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.
One of the most inherent risks is the risk of damaging healthy genes. This rather brutal issue is step one of risk management. It also means large sequences of amino acids that must be checked, ...
Zacks.com on MSN
CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors
In the latest close session, CRISPR Therapeutics AG (CRSP) was down 8.7% at $55.52. The stock fell short of the S&P 500, ...
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...
The Colossal BioVault and World Preservation Lab is a nine-figure initiative in the UAE. In addition, the UAE led an initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results